NewAmsterdam Pharma Company N.V. (NAMS)
Nasdaq: NAMS · Pharmaceutical Preparations · Narrden, NL · filing with the SEC since 2022
Who runs NewAmsterdam Pharma Company N.V.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Davidson Michael H.
Chief Executive Officer. First filing Dec 2023, latest Sep 15, 2026, 7 filings in all.
Officers reporting now
6
of 13 people with a filing in the last fifteen months
Directors reporting now
7
19 people on the record since 2023
Officerssales are open-market, Oct 2, 2025 to Oct 2, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kastelein Johannes Jacob Pieter | Chief Scientific Officer | Dec 2023 | Oct 2, 2026 | 8 · $15.5M |
| Davidson Michael H. | Chief Executive Officer | Dec 2023 | Sep 15, 2026 | 9 · $25.3M |
| Gunning Robert William | Vice President, Controller | Aug 2026 | Sep 3, 2026 | none |
| Kooij Louise Frederika | Chief Accounting Officer | Dec 2023 | Jul 22, 2026 | 16 · $16.8M |
| Somaiya Mayur Ian | Chief Financial Officer | Dec 2023 | Jan 22, 2026 | 6 · $3.4M |
| Kling Douglas F | Chief Operating Officer | Dec 2023 | Jul 17, 2025 | none |
Directorssales are open-market, Oct 2, 2025 to Oct 2, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Smither John W | director | Dec 2023 | Sep 9, 2026 | 1 · $0.00 |
| Lange Louis G | director | Dec 2023 | Mar 12, 2026 | 3 · $2.2M |
| Gulfo Adele M. | director | Apr 2025 | Jan 9, 2026 | none |
| Lewis William | director | Jan 2024 | Jan 9, 2026 | none |
| Mckenna Mark C. | director | Jul 2024 | Jan 9, 2026 | none |
| Van Der Kamp Hilde Johanna | director | Dec 2023 | Jan 9, 2026 | none |
| Topper James N | director | Dec 2023 | Sep 17, 2025 | none |
Earlier names on the record21, newest filing first
Marino Michael F III · officer · last filing Jun 2025Audet Juliette Berangere · officer · last filing May 2025Jones William A Jr · officer · last filing Jan 2025Forbion Capital Fund IV Cooperatief U.A. · 10% owner · last filing Jan 2025Forbion Growth Management B.V. · 10% owner · last filing Jan 2025Forbion Growth Opportunities Fund I Cooperatief U.A. · 10% owner · last filing Jan 2025Forbion IV Management B.V. · 10% owner · last filing Jan 2025Forgrowth Nap B.V. · 10% owner · last filing Jan 2025Bain Capital Life Sciences Fund II, L.P. · 10% owner · last filing Dec 2024Bain Capital Life Sciences Fund III, L.P. · 10% owner · last filing Dec 2024Bain Capital Life Sciences III General Partner, LLC · 10% owner · last filing Dec 2024Bain Capital Life Sciences Investors II, LLC · 10% owner · last filing Dec 2024Bain Capital Life Sciences Investors, LLC · 10% owner · last filing Dec 2024Bcip Life Sciences Associates, LP · 10% owner · last filing Dec 2024Bcls Fund III Investments Gp, LLC · 10% owner · last filing Dec 2024Bcls Fund III Investments, LP · 10% owner · last filing Dec 2024Bcls II Investco (Gp), LLC · 10% owner · last filing Dec 2024Bcls II Investco, LP · 10% owner · last filing Dec 2024Joustra Wouter · director · last filing Jul 2024Downing Nicholas · director · last filing Dec 2023Slootweg Hugo Alexander · director · last filing Dec 2023
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.